During the past decade, ZNS Siegen im MVZ Weidenau conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ZNS Siegen im MVZ Weidenau" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (1 trials) and "Depressive Disorder, Treatment-Resistant" (1 trials). Many other conditions were trialed in "ZNS Siegen im MVZ Weidenau" in a lesser frequency.

Most popular intervention types in "ZNS Siegen im MVZ Weidenau" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials), "Donepezil" (1 trials) and "Galantamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "ZNS Siegen im MVZ Weidenau" are 6 trials for "All" genders.

Currently, there are NaN active trials in "ZNS Siegen im MVZ Weidenau". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ZNS Siegen im MVZ Weidenau, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ZNS Siegen im MVZ Weidenau, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".